Erratum to: Reserpine Is the New Addition into the Repertoire of AcrB Efflux Pump Inhibitors [ Molecular Biology , 2019, Vol. 53, No. 4, pp. 596–605]

A. Shaheen; W. A. Afridi; S. Mahboob; M. Sana; N. Zeeshan; F. Ismat; O. Mirza; M. Iqbal; M. Rahman

doi:10.1134/S0026893319090012

Erratum to: Reserpine Is the New Addition into the Repertoire of AcrB Efflux Pump Inhibitors [Molecular Biology, 2019, Vol. 53, No. 4, pp. 596–605]

Authors: Shaheen A.¹^,2, Afridi W.A.¹, Mahboob S.¹, Sana M.¹, Zeeshan N.², Ismat F.¹, Mirza O.³, Iqbal M.¹, Rahman M.¹
Affiliations:
1. Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE)
2. Department of Biochemistry and Biotechnology, University of Gujrat, Hafiz Hayat Campus
3. Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen
Issue: Vol 53, No 5 (2019)
Pages: 776-776
Section: Erratum
URL: https://journals.rcsi.science/0026-8933/article/view/164085
DOI: https://doi.org/10.1134/S0026893319090012
ID: 164085

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription Access

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

erratum

About the authors

A. Shaheen

Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute
for Biotechnology and Genetic Engineering (NIBGE); Department of Biochemistry and Biotechnology, University of Gujrat, Hafiz Hayat Campus

Email: moazur.rahman@fulbrightmail.org
Pakistan, Faisalabad, 44000; Gujrat, 50700